This book deals with an increasingly important phenomenon for competitiveness and innovation in industry: namely, the growing use of basic scientific principles in industrial research. It focuses on the pharmaceutical industry, and discusses how recent significant developments in molecular biology and genetic engineering are influencing the strategies of drug companies, their organization of internal research, their relationships with scientific institutions, the market structure of the industry, and the productivity of drug research.